Health Trials

About this trial

MAGNETO is a French medico-economic study on preoperative localization in breast cancer surgery. The main objective is to conduct a cost-consequence analysis comparing magnetic clip localization with the use of metallic wires for the preoperative identification of non-palpable breast lesions. The choice of localization method is left to the physician's and center's discretion. The study is non-interventional (with only questionnaires and data collection), prospective, and multicenter, with patient follow-up lasting up to six months after breast surgery.

Eligibility criteria

Qualifiers

I1. Female aged ≥ 18 years;

I2. Patient presenting with a unifocal and unilateral lesion of invasive carcinoma or in situ;

I3. Indication for first breast-conserving treatment with the need for preoperative localization of the lesion, regardless of the associated lymph node procedure;

I4. Patient affiliated with a health insurance system;

Disqualifiers

E.1. Psychological, family, or sociological condition that may potentially compromise adherence to the treatment protocol and follow-up;

E.2. Bilateral surgery required;

E.3. Patient with metastatic breast cancer;

E.4. Multifocal or benign lesions;

Trial design

Treatments tested in this trial

  • magnetic clip localization
  • metallic wire localization.
  • Breast cancer surgery

Treatment groups

772 Participants
are divided into 2 treatment groups

Locations

7
Centre Léon Bérard69008, Lyon France
Hospices Civils de Lyon Hopital de la Croix rousse69004, Lyon France
Institut de Cancérologie de Lorraine (ICL)54519, Nancy France
Hôpital Nord -Ouest Val d'Oise (NOVO)95300, Pontoise France

Sponsors and collaborators

Centre Leon Berard

Lead sponsor

Source ClinicalTrials.gov